Related Experiment Videos
Viral hepatitis and the anaesthetist
Canadian Anaesthetists' Society Journal
|May 1, 1984
Summary
Operating room personnel face viral hepatitis risks. Awareness of Hepatitis A (HAV), Hepatitis B (HBV), and Non-A Non-B hepatitis (NANB) transmission, along with prophylaxis, is crucial for anaesthetist safety.
Area of Science:
- Medicine
- Hepatology
- Infectious Diseases
Background:
- Viral hepatitis poses a significant occupational hazard to operating room personnel, particularly anaesthetists.
- Understanding transmission routes for Hepatitis A (HAV), Hepatitis B (HBV), and Non-A Non-B hepatitis (NANB) is essential for prevention.
- Anaesthetists must be aware of patient risk groups and diagnostic challenges associated with these viral infections.
Purpose of the Study:
- To outline the risks of viral hepatitis for anaesthetists.
- To review the characteristics, transmission, and prophylaxis of HAV, HBV, and NANB.
- To highlight diagnostic considerations for postoperative hepatic dysfunction.
Main Methods:
- Review of viral hepatitis types relevant to anaesthetic practice.
- Discussion of transmission routes (faecal/oral, blood contact).
- Overview of prophylactic measures, including Gamma globulin, Hepatitis B Immune Globulin, and Hepatitis B vaccine.
Main Results:
- Hepatitis A (HAV) is primarily faecal/oral; carriers are rare, but acute/incubating infections pose diagnostic challenges.
- Hepatitis B (HBV) and Non-A Non-B hepatitis (NANB) are blood-borne with high carriage rates.
- NANB is a diagnostic challenge, often diagnosed by exclusion, and implicated in over 90% of posttransfusion hepatitis cases.
Conclusions:
- Anaesthetists must minimize contact with blood and saliva to prevent viral hepatitis exposure.
- Prophylaxis strategies, including vaccination for HBV, are vital.
- Effective management requires awareness of specific viral hepatitis types and their associated risks and diagnostic complexities.